FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileAclarion, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
ACONW
Aclarion, Inc. Stock AnalysisComprehensive stock analysis for Aclarion, Inc. (ACONW) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisACONW
ACONW
Aclarion, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
ACONW
  1. Home
  2. Stocks
  3. Aclarion, Inc.

Aclarion, Inc.

🇺🇸ACONW•NASDAQ

Aclarion, Inc.

🇺🇸ACONW•NASDAQ
Market cap
$10.93K
Sentiment

Your view on ACONW

Mkt Cap
$10.93K
Sentiment
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Aclarion, Inc.

Industry
Medical - Healthcare Information Services
Sector
Healthcare
CEO
Brent Ness
Headquarters
8181 Arista Place, Broomfield, CA, US
Industry
Medical - Healthcare Information Services
Sector
Healthcare
CEO
Brent Ness
Headquarters
8181 Arista Place, Broomfield, CA, US
Description

Aclarion, Inc. is a healthcare technology firm specializing in software development for magnetic resonance spectroscopy (MRS) within the U.S. market. Its flagship product is the NOCISCAN-LS Post-Processor suite.

This comprehensive suite includes NOCICALC-LS, which processes magnetic resonance spectroscopy (MRS) data from spinal discs to quantify degenerative pain biomarkers, and NOCIGRAM-LS, a vital clinical decision support tool. Initially named Nocimed, Inc., the company adopted the Aclarion, Inc. moniker in December 2021.

Established in 2008, Aclarion, Inc. maintains its headquarters in San Mateo, California.

Financial Data

Stock Data

Price chart, volume, and trading data.

FRC Fair Value Algorithm

What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.

About this section

Fair value for Aclarion, Inc. from FRC's valuation model, read against the market price. ACONW last traded at $0.02; the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Aclarion, Inc.. Starting points for Aclarion, Inc.: EPS -$3.64, beta 1.21 — an Medical - Healthcare Information Services name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Aclarion, Inc.. Aclarion, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Aclarion, Inc.. Trailing twelve-month EPS for Aclarion, Inc. stands at -$3.64. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Third partyAs of Nov 18, 2026 · USD

Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.

Earnings Estimate

EPSCurrent QtrDec 2026Next QtrMar 2027Current YearFY Dec 2026Next YearFY Dec 2027
Avg. estimate-$1.16-$1.51-$4.74-$3.06
Low estimate-$1.16-$1.51-$4.95-$3.19
High estimate-$1.16-$1.51-$4.53-$2.93
No. of analysts1111
Year-ago EPS-$3.60-$1.34-$13.611—
Growth+67.8%-12.7%——

1Year-ago EPS includes one-time items; growth not shown.

Revenue Estimate

RevenueCurrent QtrDec 2026Next QtrMar 2027Current YearFY Dec 2026Next YearFY Dec 2027
Avg. estimate$31559.00$40000.00$109467.00$233365.00
Low estimate$31559.00$40000.00$105821.00$222124.00
High estimate$31559.00$40000.00$113115.00$244615.00
No. of analysts1112
Year-ago revenue$18479.00$21140.00$75730.00—
Growth+70.8%+89.2%+44.5%—

Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep; as of Nov 18, 2026. Not FRC research or a recommendation.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Aclarion, Inc.. Aclarion, Inc. has reported as a listed company since 2022. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold ACONW18 companies
Compare ACONW with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis

Peer companies

Market cap

  • APYIAspyra Inc.Medical - Healthcare Information Services$34
  • BBLNFBabylon Holdings LimitedMedical - Healthcare Information Services$2,561
  • ETAOFETAO International Co., Ltd.Medical - Care Facilities$2,049
  • FDBHFounders Bay HoldingsInformation Technology Services$15,022
  • MDXLMediXall Group, Inc.Medical - Healthcare Information Services$20,551
  • NHELNatural Health Farm Holdings Inc.Medical - Healthcare Information Services$16,219

More Medical - Healthcare Information Services companies

  • PINCPremier, Inc.CBOE$2.3B
  • PKY.AXPathkey.AI LtdASX
  • PMCUFPro Medicus LimitedOTC$8.4B
  • PME.AXPro Medicus LimitedASX
  • PPJEPPJ Healthcare Enterprises, Inc.OTC$890,484
  • PPRGPatient Portal Technologies, Inc.OTC$1,580
  • PRVAPrivia Health Group, Inc.NASDAQ$3.2B
  • REFGMedical Cannabis Payment Solutions, Inc.OTC$60,838
  • RHT.AXResonance Health LimitedASX
  • RQHTFReliq Health Technologies Inc.OTC$3M
  • RSLBFRaySearch Laboratories AB (publ)OTC$822M
  • RSLTResilient Healthcare CorpPNK$2M
Open Comparable Analysis
Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold Aclarion, Inc., and how their positions are changing. At a $10,933 market value, institutional positions materially move Aclarion, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by Aclarion, Inc. executives and directors. Shares of Aclarion, Inc. have traded between $0.02 and $0.05 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Aclarion, Inc.. Coverage tracks Aclarion, Inc. within Medical - Healthcare Information Services (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Aclarion, Inc.

ACONW Analysis
Fair
Past5
Growth1
Health5
Profit1
Value1

News

Latest Market News